BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The 3rd Obesity and Weight Loss Drug Development Summit is the
  place to be for experts in weight loss drug development tackling the obe
 sity epidemic. This year\, we're evaluating the obesity landscape\, divin
 g deep into the game-changing potential of novel targets and the latest G
 LP combination therapies to manage side effects and personalise patient t
 reatment.\n\nHear from the titans of the pharmaceutical industry - Eli Li
 lly\, Novo Nordisk\, Boehringer Ingelheim as well as innovative biotechs 
 including\, Altimmune\, High Tide Therapeutics\, and iBio\, and many more
  - as they share their groundbreaking research and strategies for develop
 ing more effective\, tolerable\, and long-lasting weight management solut
 ions.\n\nObesity rates are increasing\, and the pressure is on for real c
 hange. Don't miss this pivotal opportunity to network with 70+ obesity sc
 ientists and drug development experts forge collaborations\, and be part 
 of the solution. The future of weight loss treatment is being written now
  - be there!\n\nURLs:Tickets: https://go.evvnt.com/2904709-2?pid=185Broch
 ure: https://go.evvnt.com/2904709-3?pid=185\n\nTime: 8:00 AM - 4:10 PM\n\
 nPrices:Industry Pricing - Conference + 3 Workshops / Full Day: USD 4197.
 00\,Industry Pricing - Conference + 1 Workshop: USD 3398.00\,Industry Pri
 cing - Conference Only: USD 2999.00\,Academic Pricing - Conference + 3 Wo
 rkshops / Full Day: USD 3597.00\,Academic Pricing - Conference + 1 Worksh
 op: USD 2931.00\,Academic Pricing - Conference Only: USD 2599.00\,Vendor 
 Pricing - Conference + 3 Workshops / Full Day: USD 5097.00\,Vendor Pricin
 g - Conference + 1 Workshop: USD 4166.00\,Vendor Pricing - Conference Onl
 y: USD 3699.00\n\nSpeakers: Alessandro Pocai\, Senior Director - Cardiova
 scular\, Metabolism\, PH and Retinal Research\, Scientific Strategy and I
 nnovation\, Johnson and Johnson\, Brandy Bennett\, Head Of Obesity Strate
 gy and Business Operations\, Regeneron\, Charlie Harris\, Associate Vice 
 President\, Eli Lilly\, Evan Frary\, Head of Medical Affairs\, Zealand\, 
 Faraz Naqvi\, Medical Director\, Ambrosia Biosciences\, Hariprasad Vankay
 alapati\, Chief Scientific Officer\, Biolexis\, Jay Caplan\, Founder and 
 President\, Fractyl Therapeutics\, Jay Olson Biotechnology\, Equity Resea
 rch Analyst\, Oppenheimer and Co.\, Jill Kompa\, Senior Global Program Re
 gulatory Director\, RA lead Cardiovascular-Metabolism\, Novartis\, Jingyu
  Julia Luan\, Executive Regulatory Science Director\, AstraZeneca\, John 
 Suschak\, Senior Director\, Translational Science\, Altimmune\, Laurent A
 udoly\, Chief Executive Officer\, Prive Bio\, Leigh MacConell\, Chief Dev
 elopment Officer\, High Tide Therapeutics\, Linda Sasset\, Senior Scienti
 st\, RenBio\, Mafalda Pereira\, Lab Head and Senior Scientist\, Boehringe
 r Ingelheim\, Martin Brenner\, Chief Executive and Chief Scientific Offic
 er\, iBio\, Rahul Dhanda\, Co-Founder and Chief Executive Officer\, Synti
 s Bio\, Robert Gabbay\, Chief Medical Officer and Senior Vice President a
 t Joslin Diabetes Center and Associate Professor of Medicine\, Harvard Un
 iversity\, Sharath Hedge\, Chief Scientific Officer\, Congruence Therapeu
 tics\, Steven Dickman\, Founder and Chief Executive Officer\, CBT Advisor
 s\, Teo Uysal\, Chief Executive Officer\, ERX Pharmaceuticals\, Yajing Zh
 u\, Head of Real World Science: Obesity and Liver\, Novo Nordisk\n
DTEND:20250716T161000
DTSTAMP:20260512T232948Z
DTSTART:20250714T080000
LOCATION:Hilton Boston Back Bay\, 40 Dalton Street\, Boston\, Massachusett
 s\, 02115\,
SEQUENCE:0
SUMMARY:The 3rd Obesity and Weight Loss Drug Development Summit is the pla
 ce to be for experts in weight loss drug development tackling the obesity
  epidemi...
UID:6aa2317f-0102-4ccd-8e42-991ec5cb5cf2
END:VEVENT
END:VCALENDAR